Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $35.4300 (4.78%) ($35.4300 - $35.4300) on Thu. Mar. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.78% (three month average) | RSI | 30 | Latest Price | $35.4300(4.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 2.2% a day on average for past five trading days. | Weekly Trend | IOVA declines -9.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(47%) XBI(44%) ARKG(42%) IWO(41%) IWC(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.89% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-11%) TBT(-6%) UNG(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.89% (StdDev 3.78%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $8.92(-74.82%) | Resistance Level | $39.2 | 5 Day Moving Average | $33.53(5.67%) | 10 Day Moving Average | $34.72(2.04%) | 20 Day Moving Average | $39.2(-9.62%) | To recent high | -32.7% | To recent low | 11.8% | Market Cap | $5.188b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |